Softgel Capsules Market Size, Share & Industry Analysis, By Type (Gelatin Capsules and Non Animal Softgel Capsules {Starches, Pullulan, and Others}), By Application (Prescription Medicines, OTC, and Nutraceutical), By Manufacturers (Pharmaceutical Companies, Nutraceutical Companies, and Others), and Regional Forecast, 2026-2034

The global softgel capsules market size was valued at USD 7.87 billion in 2025. The market is projected to grow from USD 8.32 billion in 2026 to USD 13.46 billion by 2034, exhibiting a CAGR of 6.20% during the forecast period. North America dominated the softgel capsules market with a market share of 35.58% in 2025.

The softgel capsules market is growing steadily over the forecast period. The market serves both nutraceutical and cosmetic industries that offer convenient, easy-to-swallow, and formulation-friendly dosage forms. Softgel capsules are widely used for oils, lipid-based ingredients, vitamins, specialty actives, and drugs that require improved absorption and better stability. As consumers increasingly prefer preventive healthcare products and branded wellness supplements, manufacturers are witnessing stronger demand for high-quality encapsulation formats. Furthermore, pharmaceutical companies continue to use softgels to improve bioavailability, support product differentiation, and enhance patient compliance. These factors collectively fuel market growth, with a strong focus on capacity expansion, delivery innovation, and premium dosage development.

Key companies operating in the market are increasingly focusing on expanding their product offerings and improving manufacturing capabilities to strengthen their market presence. 

• For instance, in June 2025, Robinson Pharma expanded its manufacturing capabilities, including a new high-speed liquid production line and additional capacity for tablets, softgel, and capsules. The development reflected the investments softgel manufacturers are making to meet rising demand from supplement and wellness brands. Such capacity additions improve turnaround time and support future market growth by enabling larger-scale and more diversified softgel production.

Furthermore, leading players in the softgel capsules industry, such as Lonza, Sirio Pharma, Catalent Inc, and Hunan Er Kang Pharmaceutical Co., Ltd, are focusing on research and development and strategic partnerships, expanding their offerings to strengthen their market positions.

Download Free sample to learn more about this report.

SOFTGEL CAPSULES MARKET TRENDS

Increasing Use of Softgels for Bioavailability Enhancements is a Prominent Market Trend Observed

An emerging key market trend is the increasing use of softgels to improve bioavailability. Many pharmaceutical and nutraceutical ingredients have poor water solubility, limiting their absorption in the body. Softgel capsules help address this challenge and deliver Active Pharmaceutical Ingredients (APIs) in a pre-dissolved or lipid-based form. This can improve absorption, support faster release, and enhance overall product performance. As more manufacturers focus on improving efficacy and patient outcomes, demand is increasing for softgel technologies that can enhance bioavailability, especially for complex and poorly soluble formulations. Following the trend, various key companies are focusing on new product launches in the soft gel format.

• For instance, in March 2026, SIRIO Europe introduced Life Chews, a patented plant-based chewable jelly tablet enabling high-load drug delivery of lipid-soluble actives while mitigating oxidation and taste liabilities.

MARKET DYNAMICS

MARKET DRIVERS

Growing Consumption of Nutraceuticals and Dietary Supplements to Drive Growth

One of the major factors driving the market is consumers' increasing focus on preventive healthcare and daily wellness management. As the consumption of vitamins, omega-3 supplements, herbal extracts, immunity products, and beauty-from-within formulations increases, the market demand also rises. Manufacturers need dosage forms that are convenient, easy to swallow, and suitable for liquid or oil-based ingredients. Softgel capsules meet these criteria and help improve consumer adherence. They are also highly suitable for encapsulating sensitive and lipophilic ingredients, making them a suitable option for nutraceutical brands seeking to improve formulation stability and user experience. Such advantages encourage key companies to enter into strategic partnerships and drive overall softgel capsules market growth.

• For instance, in October 2025, Caldic and Lonza Capsugel entered an exclusive North American distribution partnership. The partnership enabled them to showcase new nutraceutical product applications featuring Lonza’s branded ingredients. Such development highlights expanding partnerships by key companies to expand their commercial reach.

Download Free sample to learn more about this report.

MARKET RESTRAINTS

Quality Control and Stability Challenges in Softgel Capsules Restricting Market Growth

Softgel capsules are highly sensitive to formulation balance, shell composition, and storage conditions. Therefore, quality control and stability present as a significant market restraint. When the shell and fill material do not interact properly, manufacturers face issues such as leakage, shell deformation, cross-linking, and reduced dissolution performance, all of which directly affect product quality and shelf stability. These issues become more critical under high-temperature, high-humidity conditions, where the capsule shell can absorb moisture, swell, or lose its intended physical properties. This mandates that companies implement tighter environmental controls, more stability testing, and additional formulation optimization, which increases manufacturing costs.

• For instance, in July 2025, BMC Chemistry published article in the Journal of Cheminformatics titled ‘How can the leakage phenomenon of gelatin-based soft capsule shells be estimated?’. The report stated that the leakage behavior of gelatin-based soft capsules increases with temperature and humidity, and the study found that leakage was linked to swelling of the gelatin shell during storage. Such studies highlight the environmental sensitivity of softgel capsules and can create real stability and quality problems, making manufacturing and long-term storage more challenging.

MARKET OPPORTUNITIES

Growing Demand for Plant-Based Capsules to Offer Lucrative Market Growth Avenues.

Elevated demand for plant-based capsules acts as a strong growth opportunity for the global market. Consumer demand for alternative shell materials is rising among consumers who follow plant-based lifestyles or have religious, dietary, or ethical restrictions on animal-derived ingredients. That shift is encouraging manufacturers to invest in non-animal, plant-based softgel technologies that can expand brand reach and help products appeal to a broader consumer base. These factors are also creating new room for innovation, as companies are developing plant based softgels that can still support stability, attractive appearance, and compatibility with more complex fill formulations. As supplement and wellness brands continue to target vegan and premium-positioned users, plant-based capsule offerings are becoming an important way to differentiate products and unlock new demand pools.

• For instance, in May 2025, Aenova Group announced at its Vitafoods 2025 company event that it would showcase its softgel capabilities, including VegaGels and chewable softgels. Such development supports the market growth opportunity as manufacturers are actively promoting plant-based and alternative softgel formats.

MARKET CHALLENGES

Rising Cost Pressure from Raw Materials and Manufacturing Inputs Poses a Significant Challenge for Market Growth

A major challenge for the market is rising cost pressures from raw materials and manufacturing inputs. Softgel production relies heavily on gelatin and other specialty ingredients, and the manufacturing process is more complex than that of conventional solid oral dosage forms. When gelatin prices fluctuate or logistics disruptions tighten supply, manufacturers face higher input costs that directly pressure margins and make pricing less predictable. Also, softgel production requires rigorous environmental controls, precise material handling, and higher operating discipline, which increase manufacturing expenses before packaging and distribution are considered.

• For instance, in July 2025, ChemAnalyst published a market article reporting that gelatin prices in Germany were likely to keep rising due to port congestion across Northern Europe, labor shortages, low Rhine River water levels, and stronger export demand. Such factors showcase how raw-material price volatility and supply-chain disruption can raise input costs for capsule manufacturers and make softgel production more expensive and operationally difficult.

SOFTGEL CAPSULES MARKET Segmentation Analysis

By Type

High Utilization of Gelatin Capsules to Lead the Segmental Growth

Based on the type, the market is categorized into gelatin capsules and non-animal softgel capsules {starches, pullulan, and others}.

Among these, the gelatin capsules segment dominated the market. These capsules are the most established softgel format and are widely used across both pharmaceutical and nutraceutical applications. Their dominance is supported by greater familiarity with processes, broad compatibility with oil- and liquid-based fills, strong capsule stability, and easier large-scale manufacturing, which together make them more commercially practical than non-animal alternatives. In addition, gelatin softgels continue to witness technological improvements, helping manufacturers maintain performance and cost advantages while meeting high-volume demand.

• For instance, in November 2023, Rousselot, Darling Ingredients’ health brand, announced that its StabiCaps specialized gelatin technology received a U.S. patent for improving soft gel capsule stability and efficacy. The company stated that the technology helps address crosslinking, a key issue that can slow or prevent capsule dissolution, thereby strengthening the performance of gelatin-based softgels.

The non-animal segment is expected to grow at a CAGR of 7.54% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Higher Consumption of Prescription Medicine to Boost the Segment Growth

Based on application, the market is segmented into prescription medicines, OTC, and nutraceuticals.

The prescription medicines segment dominated with the largest softgel capsules market share. Many prescription drugs require accurate dosing, improved bioavailability, and patient-friendly oral delivery. These can be achieved using softgel formats. Softgels are useful for poorly soluble APIs, liquid fills, and specialized oral delivery needs, which increases their adherence in regulated prescription therapies. As a result, pharmaceutical developers are increasingly using softgel technologies to improve formulation performance and expand treatment options in prescription care.

• For instance, in October 2025, Bayer received approval from the U.S. FDA for Lynkuet (elinzanetant) 60mg capsules, a dual Neurokinin (NK) targeted therapy, 1 neurokinin 1 (NK1) and Neurokinin 3 (NK3) receptor antagonist, for the treatment of moderate to severe hot flashes due to menopause. Such developments highlight how prescription drug companies continue to commercialize capsule-based therapies to deliver differentiated, patient-friendly treatment options in regulated markets.

In addition, the nutraceutical segment is projected to grow at a CAGR of 7.60% during the forecast period.

By Manufacturers

Large-scale Demand for Commercial Drug Portfolio to Drive Pharmaceutical Companies Segment Growth

Based on manufacturers, the market is segmented into pharmaceutical companies, nutraceutical companies, and others.

The pharmaceutical companies segment dominated the market. They have stronger regulatory capabilities, larger commercial drug portfolios, and higher requirements for advanced oral dosage technologies than other manufacturer groups. Also, their large scale allows them to invest in formulation development, quality systems, clinical validation, and specialized delivery platforms, thereby strengthening their position in softgel production and commercialization. Underscoring the high stakes, key companies are expanding their manufacturing capabilities to meet growing demand.

• For instance, in January 2026, Robinson Pharma Inc., a manufacturer of dietary supplements, expanded its veggie softgel manufacturing capabilities to meet rapidly growing demand for plant-based and vegan supplement formats.

The nutraceutical companies segment is projected to grow at a CAGR of 6.07% over the study period.

Softgel Capsules Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024 at USD 2.65 billion and maintained its leading position in 2025 at USD 2.80 billion. The North American market is growing strongly as supplement consumption is already well established, creating a large, repeat-use customer base for softgel formats. In the U.S., adults use dietary supplements, and that supports steady demand for softgel capsules in vitamins, specialty supplements, and wellness products.

U.S. Softgel Capsules Market

Given North America's substantial contribution and the U.S. dominance in the region, the U.S. market is estimated at around USD 2.69 billion in 2026, accounting for roughly 32.36% of the global market.

Europe

Europe is projected to grow at 5.64% over the coming years, the second-highest among all regions, and reach a valuation of USD 2.53 billion by 2026. The region is witnessing growth as its aging population is increasing long-term consumption of easy-to-administer medicines and daily health supplements. Moreover, demand for immunity, wellness, and preventive health products remains strong in key markets such as Germany, France, and Italy, supporting continued uptake of softgel-based nutraceutical and pharmaceutical products.

U.K. Softgel Capsules Market

The U.K. market is estimated at around USD 0.40 billion in 2026, representing roughly 4.78% of the global market.

Germany Softgel Capsules Market

Germany's market is projected to reach approximately USD 0.63 billion in 2026, equivalent to around 7.53% of the global market.

Asia Pacific

Asia Pacific is estimated to reach USD 1.83 billion in 2026 and secure the position of the third-largest region in the market. Asia Pacific is growing fastest as rising incomes, rapid urbanization, and stronger health awareness are expanding demand for nutraceuticals and convenient oral dosage forms. Broader Asia Pacific supplement demand is also projected to expand strongly, which creates a large runway for softgel capsule manufacturing and consumption.

Japan Softgel Capsules Market

The Japanese market in 2026 is estimated at around USD 0.44 billion, accounting for approximately 5.24% of the global market.

China Softgel Capsules Market

China's market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.64 billion, representing approximately 7.67% of global sales.

India Softgel Capsules Market

The Indian market in 2026 is estimated at around USD 0.25 billion, accounting for roughly 3.00% of global revenues.

Latin America and the Middle East & Africa

The Latin America and the Middle East & Africa regions are expected to witness moderate market growth during the forecast period. The Latin America market is set to reach a valuation of USD 0.51 billion in 2026. The region is witnessing growth as consumers are spending more on preventive wellness, vitamins, and functional supplements, especially in large countries such as Brazil. The dietary supplements market is projected to grow strongly, and that momentum supports higher use of softgels as a convenient format for oils, fat-soluble vitamins, and condition-specific wellness products. In the Middle East & Africa, the GCC is set to reach USD 0.21 billion in 2026.

South Africa Softgel Capsules Market

The South African market is projected to reach approximately USD 0.10 billion by 2026, accounting for roughly 1.25% of global revenue.

COMPETITIVE LANDSCAPE

Key Industry Players

Emphasis on Research and Development by Key Players to Propel Market Progress

The global market is highly consolidated, with companies such as Lonza, Sirio Pharma, Inc, Catalent Inc, Hunan Er Kang Pharmaceutical Co., Ltd, Aenova Group GmbH, Fuji Capsule Co., Ltd., Delpharm, and Captek Softgel International Inc. holding significant global market share. Strategic partnerships, new product launches, and increased investments in the sector drive these companies' market share gains.

• For instance, in March 2025, Delpharm invested USD 200 million in its manufacturing facility at the Boucherville site, including contributions from the Canadian federal government and the signing of a 10-year commercial agreement with Sandoz.

Other notable players in the global market include Curtis Health Caps S.A, EuroCaps Ltd, and Cloverty. These companies are expected to prioritize technological advancements, strategic collaborations, and new product launches to strengthen their positions during the forecast period.

LIST OF KEY SOFTGEL CAPSULES COMPANIES PROFILED

• Lonza (Switzerland)
• Sirio Pharma (China)
• Catalent Inc. (U.S.)
• Hunan Er Kang Pharmaceutical Co., Ltd (China)
• Aenova Group GmbH (Germany)
• Fuji Capsule Co., Ltd. (Japan)
• Captek Softgel International Inc. (U.S.)
• Curtis Health Caps S.A. (Poland)
• EuroCaps Ltd (U.K.)
• ALCALÁ FARMA laboratories (SYNERLAB) (Spain)
• Cloverty (Spain)

KEY INDUSTRY DEVELOPMENTS

• February 2025: Jupiter Neurosciences Inc., a pharmaceutical company developing JOTROL, collaborated with Catalent Pharma Solutions LLC for the production of JOTROL softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease. Under the collaboration, Catalent manufactured clinical batches of JOTROL, using an optimized softgel formulation.
• December 2023: Amneal Pharmaceuticals, Inc., in collaboration with Strides Pharma Science Limited, added Icosapent ethyl acid soft gel capsules, a product referencing VASCEPA. The product was in-licensed from Strides and commercialized by Amneal. Icosapent ethyl acid soft gel capsules 0.5g and 1g are an ethyl ester of Eicosapentaenoic Acid (EPA) that is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
• September 2022: Everstone Group(Everstone) acquired a controlling stake in Softgel Healthcare (SHPL), a specialized, niche dosage-form-focused organization. The development aimed to transform SHPL into a scaled, diversified, and globally recognized contract research, development, and manufacturing organization in India.
• October 2020: Catalent launched OptiGel DR technology for the formulation and manufacturing of delayed- and enteric-release softgels. The technology enabled softgel capsules to be formed by combining pectin, a naturally derived polysaccharide, with gelatin, eliminating the need for a separate capsule-coating step.

REPORT COVERAGE

The report covers a detailed overview of global softgel capsules market analysis of the industry. It evaluates how the market is evolving due to rising demand for the product, the growing use of nutraceuticals and dietary supplements, and the increasing preference for convenient oral drug-delivery systems across different patient groups. The report also examines shifting demand with the expansion of preventive healthcare, increased consumption of vitamins and supplements, and the wider adoption of softgel formulations across pharmaceuticals, nutraceuticals, and cosmeceuticals. Additionally, it provides insights into competitive developments, manufacturing innovations, regulatory trends, product pipeline activity, and regional growth patterns, offering a comprehensive view of the market landscape. The study further highlights how rising consumer health awareness, improved bioavailability advantages of softgel formulations, and continued innovation in gelatin and plant-based capsule technologies are expected to support market expansion over the forecast period.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation